The European Medicines Agency (EMA) will this week give the green light to the treatment developed by U.S. biotech firm Regeneron and Swiss...

"An early intervention with our antibody can give a significant reduction in progression to severe disease, with continued protection for m...

Consolidated total revenue from operations stood at Rs 4,025.4 crore for the quarter under consideration against Rs 3,514.6 crore for the s...

Antibody cocktail is a combination of two drugs and its vial costs nearly Rs 60000 in the market.

About 100 Covid-19 patients have so far undergone antibody cocktail treatment at various hospitals in the city with successful outcomes.

The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatm...

The antibody cocktail is a combination of Casirivimab and Imdevimab, which are laboratory made monoclonal antibodies. The cocktail works ju...

The Mohali-based Fortis Hospital, in a statement, said the patient, who had tested positive for the infection two days ago, is a diabetic w...

Two patients in their forties took the monoclonal antibodies in Bandra’s Lilavati Hospital, two others — a 40-year-old man and a 74-year-ol...

As part of this single dose infusion-based treatment, patients with mild to moderate symptoms, are offered a cocktail of Casirivimab and Im...

“We are exploring all options to quickly make this important medicine available for Indian patients,” GSK India spokesperson told ET. Earli...

As part of this single dose infusion-based treatment, patients with mild to moderate symptoms are offered a cocktail of Casirivimab and Imd...

Regeneron and Roche's antibody cocktail has also received emergency use approval in India, and will be distributed by drugmaker Cipla. The ...

Cipla will distribute the product by leveraging its strong distribution strengths across the country, the companies said in a joint stateme...

The query was posed to the government by Justice Prathiba M Singh after Roche India, which supplies Tocilizumab in India, told the court it...

Roche said that the production process for this drug is “very complex” and the company will do everything to ensure an equitable distributi...

The results of the Phase 3 trial showed that the combination of the antibodies casirivimab and imdevimab "reduced hospitalisation or death ...